The invention relates to the therapeutic use of oligonucleotides as immunostimulatory agents in immunotherapy applications. More particularly, the invention provides immunomers and an immunostimulatory oligonucleotides for use in methods for generating an immune response or for treating a patient in need of immunostimulation. The immunomers and an immunostimulatory oligonucleotides of the invention preferably comprise novel purines. The immunomers according to the invention further comprise at least two oligonucleotides linked at their 3' ends, internucleoside linkages or functionalized nucleobase or sugar to a non-nucleotidic linker, at least one of the oligonucleotides being an immunomodulatory oligonucleotideand having an accessible 5' end.

 
Web www.patentalert.com

< Exon 1 ss of pdgf alpha gene and utilization thereof

< Antisense modulation of farnesoid X receptor expression

> Polycations capable of forming complexes with nucleic acids

> Biopolymers modified with superoxide dismutase mimics

~ 00286